Philip Van Damme is a professor of neurology at the University Hospitals in Leuven (Belgium), where he leads the Neuromuscular Reference Center. His current research focuses on genetic modifiers of amyotrophic lateral sclerosis (ALS) and disease pathways in pluripotent stem cell models derived from ALS patients. As a prominent medical expert in neurology, Dr. Van Damme has published over 200 papers in international peer-reviewed journals on ALS and related neuromuscular disorders, and he is the chair of the European Academy of Neurology (EAN) guideline panel on ALS. He previously worked as a visiting neuromuscular fellow at the Mass General Hospital in Boston and as a visiting researcher at the Day Laboratory for Neuromuscular Research at Harvard Medical School. He holds an MD from KU Leuven University.